Publication Name	World Journal of Gastroenterology
Manuscript ID	88341
Country	Italy

Received	2023-09-20 18:35
Peer-Review Started	2023-09-20 18:37
To Make the First Decision
Return for Revision	2023-10-12 17:16
Revised	2023-10-25 21:16
Second Decision	2023-11-13 06:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-11-17 08:49
Articles in Press	2023-11-17 08:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-12-04 05:29
Publish the Manuscript Online	2023-12-13 07:04

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Albumin-bilirubin score in non-malignant liver diseases should be properly validated
Manuscript Source	Unsolicited Manuscript
All Author List	Andrea Pasta, Francesco Calabrese, Maria Corina Plaz Torres, Giorgia Bodini, Manuele Furnari, Edoardo Vincenzo Savarino, Vincenzo Savarino, Edoardo Giovanni Giannini and Elisa Marabotto
Funding Agency and Grant Number
Corresponding Author	Elisa Marabotto, MD, PhD, Academic Research, Doctor, Professor, Researcher, Gastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS‐Ospedale Policlinico San Martino, Viale Benedetto XV, 6, Genoa 16132, Italy. elisa.marabotto@unige.it
Key Words	Albumin-bilirubin score; Decompensated cirrhosis; Liver disease; Non-malignant liver disease; Portal hypertension
Core Tip	The albumin-bilirubin (ALBI) score was initially proposed to evaluate liver function in patients with hepatocellular carcinoma. It proposed to validate the ALBI score to assess the risk of decompensation in patients with compensated cirrhosis. We provide a comment to highlight the preliminary nature of the evidence reported by the authors. Further studies are needed to validate the ALBI score to predict decompensation in patients with cirrhosis.
Publish Date	2023-12-13 07:04
Citation	Pasta A, Calabrese F, Plaz Torres MC, Bodini G, Furnari M, Savarino EV, Savarino V, Giannini EG, Marabotto E. Albumin-bilirubin score in non-malignant liver diseases should be properly validated. World J Gastroenterol 2023; 29(46): 6089-6091
URL	https://www.wjgnet.com/1007-9327/full/v29/i46/6089.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i46.6089

Full Article (PDF)	WJG-29-6089-with-cover.pdf
Full Article (Word)	WJG-29-6089.docx
Manuscript File	88341_Auto_Edited-JLW.docx
Answering Reviewers	88341-Answering reviewers.pdf
Audio Core Tip	88341-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	88341-Conflict-of-interest statement.pdf
Copyright License Agreement	88341-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	88341-Language certificate.pdf
Peer-review Report	88341-Peer-review(s).pdf
Scientific Misconduct Check	88341-Bing-Li L-2.png
Scientific Editor Work List	88341-Scientific editor work list.pdf